Naloxone hydrochloride impurity 1 and preparation method thereof
By treating naloxone hydrochloride under alkaline conditions and adjusting pH with acid, naloxone hydrochloride impurity 1 was successfully prepared, solving the problem of structure and source determination of unknown impurities, providing high-purity research materials, and promoting naloxone hydrochloride Research on ketone preparations and determination of storage conditions.
Patent Information
- Application Number
- CN202411528253.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-30
- Publication Date
- 2024-11-26
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
In the stability study of naloxone hydrochloride injection, unknown impurities exist, and their structure and source need to be determined to ensure the safety of medication and the basis for the formulation research.
在碱性条件下将盐酸纳洛酮与氢氧化钠或氢氧化钾溶液反应,随后用酸调节pH中性,通过反相液相色谱分离制备得到目标杂质,减压蒸除有机溶剂并冻干,制备得到的盐酸纳洛酮杂质1。
The purity of the obtained impurity 1 is more than 90%, and is used for the quality research of naloxone hydrochloride, providing a research basis for the formulation, process and storage conditions of the preparation. The raw materials are easy to obtain, the process parameters are controllable, and the reaction is mild.
Smart Images

Figure CN119019414A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a naloxone hydrochloride impurity 1 and a preparation method thereof, belonging to the technical field of pharmaceutical chemistry. Background Art
[0002] Naloxone hydrochloride is a pure opioid receptor antagonist. It has no intrinsic activity itself, but it can competitively antagonize various opioid receptors and has a strong affinity for μ receptors. Naloxone takes effect quickly and has a strong antagonistic effect. Naloxone can simultaneously reverse all effects of opioid agonists, including analgesia. Naloxone can quickly reverse the respiratory depression caused by opioids, can cause high excitement, and cause cardiovascular hyperfunction. Naloxone has an anti-shock effect. In addition, naloxone also has a recovery effect that is not related to antagonizing opioid receptors. Unlike morphine, naloxone does not produce dependence, withdrawal symptoms, and respiratory depression.
[0003] Naloxone hydrochloride is the most widely used opioid receptor antagonist in clinical practice. Its clinical indications include acute poisoning by narcotic analgesics and acute alcohol poisoning. It is first used for respiratory depression and coma caused by known or suspected opioid overdose, and can also be used for the differential diagnosis of opioid addicts.
[0004] At present, some unknown impurities have appeared in the stability study of naloxone hydrochloride injection. In order to ensure the safety of medication and fully study the quality and properties of naloxone hydrochloride injection, it is necessary to clarify the structure of these unknown impurities, attribute the source and category of the impurities, and provide a basis for determining the appropriate preparation process and storage conditions in the preparation research. Therefore, the preparation method of these impurities was studied, and the target impurities were prepared in a researchable amount, and the structure was confirmed. Summary of the invention
[0005] The purpose of the present invention is to provide a naloxone hydrochloride impurity 1 and a preparation method thereof. The prepared impurity 1 has positive significance for the formulation research, process research, and storage condition research of naloxone hydrochloride preparations. The raw materials used in the present invention are easily available, the process parameters are controllable, and the reaction is mild.
[0006] The naloxone hydrochloride impurity 1 described in the present invention has the structural formula as shown below: .
[0007] The method for preparing naloxone hydrochloride impurity 1 of the present invention comprises the following steps: (1) Dissolve naloxone hydrochloride in an alkaline solution and heat to react.
[0008] (2) Cool to room temperature, adjust the pH to neutral with acid while stirring, and filter out insoluble matter to obtain a sample solution.
[0009] (3) Separate and prepare the sample solution through preparative liquid phase, and collect the target peak solution.
[0010] (4) The collected liquid is evaporated under reduced pressure to remove the organic solvent, and then freeze-dried to obtain the target impurity.
[0011] Wherein, in the step (1), the alkaline solution used is a 0.1-0.15 mol / L sodium hydroxide aqueous solution or a potassium hydroxide aqueous solution, and the ratio of naloxone hydrochloride to the aqueous solution is 1:60 (g / mL).
[0012] In the step (1), the reaction temperature is 60-80°C and the reaction time is 24-28h.
[0013] In the step (2), the acid used is concentrated hydrochloric acid (34-36% (g / g)).
[0014] In the step (3), the conditions for preparing the liquid phase separation are: Chromatographic column: Kromail 100-5-C18 Φ30×250mm; Detection wavelength: 230nm; The mobile phase and gradient are shown in Table 1. The % in Table 1 is the volume percentage. Table 1 Mobile phase and gradient
[0015] Flow rate: 30mL / min; Injection volume: 5.5~6.5mL.
[0016] In the step (4), the temperature for distilling off the organic solvent (acetonitrile) under reduced pressure is 25-35°C.
[0017] The reaction principle of the present invention is as follows: .
[0018] The present invention uses naloxone hydrochloride as a starting material, destroys and oxidizes impurity 1 under alkaline conditions, and then adjusts the pH to neutral with acid, and then separates and purifies the target impurity 1 through reverse liquid phase preparation.
[0019] Compared with the prior art, the present invention has the following beneficial effects: The purity of the target impurity 1 prepared by the present invention reaches more than 90%, and can be used as a reference substance for the quality study of naloxone hydrochloride. The present invention has positive significance for the formulation research, process research, and storage condition research of naloxone hydrochloride preparations. The raw materials used in the present invention are easy to obtain, the process parameters are controllable, and the reaction is mild. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 HPLC spectrum of impurity 1 in Example 1.
[0021] Figure 2 Mass spectrum of impurity 1 in Example 1.
[0022] Figure 3 Hydrogen spectrum of impurity 1 in Example 1.
[0023] Figure 4 Carbon spectrum of impurity 1 in Example 1.
[0024] Figure 5 COSY spectrum of impurity 1 in Example 1.
[0025] Figure 6 HMBC spectrum of impurity 1 in Example 1.
[0026] Figure 7 HSQC spectrum of impurity 1 in Example 1. DETAILED DESCRIPTION
[0027] The specific implementation modes of the present invention are further described below in conjunction with embodiments.
[0028] Example 1 The preparation method of naloxone hydrochloride impurity 1 comprises the following steps: Weigh 1.0 g of naloxone hydrochloride raw material into a reaction bottle, add 60 mL of 0.125 mol / L sodium hydroxide aqueous solution, stir to dissolve, heat to 70°C, keep warm for 26 hours, cool to room temperature, adjust the pH to neutral with 35% concentrated hydrochloric acid while stirring, filter out insoluble matter, and obtain a sample solution. The content of the solution detected by HPLC was 5.23%.
[0029] The sample solution was separated and prepared by preparative liquid phase separation. The conditions for preparative liquid phase separation were as follows: Chromatographic column: Kromail 100-5-C18 Φ30×250mm; Detection wavelength: 230nm; The mobile phase and gradient are shown in Table 1; Flow rate: 30mL / min; Injection volume: 6±0.5mL; The target impurity peak solution was collected, acetonitrile was removed under reduced pressure at 30°C, and then freeze-dried to obtain the target impurity 1, with an HPLC content of 97.12%; ESI-MS: m / z=360.14404 ([M+H] + ); 1 H-NMR (D2O, 600MHz): δ ppm: 1.58 (1H, d), 1.89 (1H, dd), 2.23 (1H, d), 2.66 (1H, td), 3.02 (1H, dd), 3.06 (1H, m), 3.33 (1H, dd), 3.53 (1H, d), 3.92 (2H, d), 4.09 (1H, d), 4.83 (1H, s), 5.64 (2H, m), 5.92 (1H, ddt), 6.79 (1H, d), 6.85 (1H, d); 13 C-NMR (D2O, 150MHz): δ ppm 5: 22.92, 25.41, 46.05, 46.67, 4.42, 55.68, 61.30, 75.48, 80.24, 92.59, 118.80, 120.82, 122.81, 125.96, 126.06, 130.26, 138.56, 144.44, 181.63.
[0030] The HPLC spectrum of Naloxone Hydrochloride Impurity 1 is as follows: Figure 1 , mass spectrum as Figure 2 , the hydrogen spectrum is as follows Figure 3 , carbon spectrum as Figure 4 , COSY spectrum is as follows Figure 5 , HMBC spectrum is as follows Figure 6 , HSQC spectrum is as follows Figure 7 . Figure 1 The results of the corresponding chromatographic peaks are shown in Table 2.
[0031] Table 2 Chromatographic peak results
[0032] Example 2 The preparation method of naloxone hydrochloride impurity 1 comprises the following steps: Weigh 1.0 g of naloxone hydrochloride raw material into a reaction bottle, add 60 mL of 0.15 mol / L sodium hydroxide aqueous solution, stir to dissolve, heat to 60 ° C, keep warm for 24 hours, cool to room temperature, adjust the pH to neutral with 34% concentrated hydrochloric acid while stirring, filter out insoluble matter, and obtain a sample solution.
[0033] The sample solution was separated and prepared by using preparative liquid phase separation, and the conditions for the preparative liquid phase separation were the same as those in Example 1.
[0034] The target impurity peak solution was collected, acetonitrile was evaporated under reduced pressure at 35°C, and then freeze-dried to obtain the target impurity 1 with an HPLC content of 93.52%.
[0035] Example 3 The preparation method of naloxone hydrochloride impurity 1 comprises the following steps: Weigh 1.0 g of naloxone hydrochloride raw material into a reaction bottle, add 60 mL of 0.10 mol / L potassium hydroxide aqueous solution, stir to dissolve, heat to 80°C, keep warm for 24 hours, cool to room temperature, adjust the pH to neutral with 36% concentrated hydrochloric acid while stirring, filter to remove insoluble matter, and obtain a sample solution.
[0036] The sample solution was separated and prepared by using preparative liquid phase separation, and the conditions for the preparative liquid phase separation were the same as those in Example 1.
[0037] The target impurity peak solution was collected, acetonitrile was evaporated under reduced pressure at 25°C, and then freeze-dried to obtain the target impurity 1 with an HPLC content of 94.63%.
[0038] Example 4 The preparation method of naloxone hydrochloride impurity 1 comprises the following steps: Weigh 1.0g of naloxone hydrochloride API into a reaction bottle, add 60mL of 0.125mol / L potassium hydroxide aqueous solution, and stir to dissolve. Heat to 60℃ and keep warm for 28h. Cool to room temperature and adjust pH to neutral with 35% concentrated hydrochloric acid while stirring. Filter to remove insoluble matter to obtain a sample solution.
[0039] The sample solution was separated and prepared by using preparative liquid phase separation, and the conditions for the preparative liquid phase separation were the same as those in Example 1.
[0040] The target impurity peak solution was collected, acetonitrile was evaporated under reduced pressure at 30°C, and then freeze-dried to obtain the target impurity 1 with an HPLC content of 94.74%.
[0041] Example 5 The preparation method of naloxone hydrochloride impurity 1 comprises the following steps: Weigh 1.0 g of naloxone hydrochloride raw material into a reaction bottle, add 60 mL of 0.10 mol / L sodium hydroxide aqueous solution, stir to dissolve, heat to 70°C, keep warm for 28 hours, cool to room temperature, adjust the pH to neutral with 35% concentrated hydrochloric acid while stirring, filter to remove insoluble matter, and obtain a sample solution.
[0042] The sample solution was separated and prepared by using preparative liquid phase separation, and the conditions for the preparative liquid phase separation were the same as those in Example 1.
[0043] The target impurity peak solution was collected, acetonitrile was evaporated under reduced pressure at 25°C, and then freeze-dried to obtain the target impurity 1 with an HPLC content of 95.27%.
[0044] The present invention is described in detail above in conjunction with the embodiments, but the contents described are only preferred embodiments of the present invention and cannot be considered to limit the scope of implementation of the present invention. All equivalent changes and improvements made within the scope of the present invention should still fall within the scope of the patent coverage of the present invention.
Claims
1. A naloxone hydrochloride impurity 1, It is characterized in that The structural formula is as follows: .
2. A method for preparing the naloxone hydrochloride impurity 1 according to claim 1, It is characterized in that The following steps are involved: (1) dissolving naloxone hydrochloride in an alkaline solution and heating the solution to react; (2) Cooling to room temperature, adjusting the pH to neutral with acid while stirring, filtering to remove insoluble matter, and obtaining a sample solution; (3) Separating and preparing the sample solution through preparative liquid phase and collecting the target peak solution; (4) The collected solution is evaporated under reduced pressure to remove the organic solvent, and then freeze-dried to obtain the target impurity 1.
3. The method for preparing naloxone hydrochloride impurity 1 according to claim 2, It is characterized in that In step (1), the alkaline solution used is a 0.1-0.15 mol / L sodium hydroxide aqueous solution or a potassium hydroxide aqueous solution, and the ratio of naloxone hydrochloride to the aqueous solution is 1:60 (g / mL).
4. The method for preparing naloxone hydrochloride impurity 1 according to claim 2, It is characterized in that In step (1), the reaction temperature is 60-80°C and the reaction time is 24-28h.
5. The method for preparing naloxone hydrochloride impurity 1 according to claim 2, It is characterized in that In step (2), the acid used is concentrated hydrochloric acid with a mass concentration of 34-36%.
6. The method for preparing naloxone hydrochloride impurity 1 according to claim 2, It is characterized in that In step (3), the conditions for preparing the liquid phase separation are: Chromatographic column: Kromail 100-5-C18 Φ30×250mm; Detection wavelength: 230nm; Mobile phase and gradient: 0 min, 87% water-13% acetonitrile; 10 min, 87% water-13% acetonitrile; 11 min, 10% water-90% acetonitrile; 19 min, 10% water-90% acetonitrile; 20 min, 87% water-13% acetonitrile; 30 min, 87% water-13% acetonitrile; Flow rate: 30mL / min; Injection volume: 5.5~6.5mL.
7. The method for preparing naloxone hydrochloride impurity 1 according to claim 2, Features: In step (4), the temperature for distilling off the organic solvent under reduced pressure is 25 to 35°C.
Citation Information
Patent Citations
Naloxone hydrochloride compound with high purity
CN101768164A
Method for determining naloxone hydrochloride impurity D by using liquid chromatography
CN116482286A
